The short answer
Take oral iron separately from an ibandronate tablet, with ibandronate first and at least 60 minutes before iron. The supported concern is interference with oral drug absorption. The inspected sources do not establish a separate, pair-specific increase in toxicity from this combination.
What this answer covers
Oral iron preparations with oral ibandronate sodium. Intravenous iron and intravenous ibandronate are outside this intestinal co-administration assessment.
- Supplement or preparation
- Iron
- Medication ingredient
- ibandronate
Why does this combination need attention?
Iron is explicitly listed among mineral products likely to interfere with absorption. The label therefore directs a 60-minute wait before other oral products. It does not compare individual iron salts, prove that a particular amount causes treatment failure, or identify a unique iron-ibandronate toxic effect. An absorption precaution alone does not establish those stronger outcomes.
How should the doses be scheduled?
On the dosing morning, take the ibandronate tablet with a full glass of plain water while upright, before the first food, drink other than water or oral medicine. Wait at least 60 minutes before other oral products and remain upright as directed. A later meal can be a practical supplement time. Do not borrow a 30-minute rule from another osteoporosis medicine.
What should I discuss with my pharmacist?
Do not stop treatment for diagnosed iron deficiency simply because its timing needs adjustment. Include iron in multivitamins and other combined products when planning the schedule. New stomach or swallowing symptoms should be assessed by a clinician and cannot automatically be attributed to a proven toxic interaction between these two products.
What are the limits of the evidence?
The absorption and timing precaution is supported, while an additional side-effect claim remains insufficiently substantiated. A trial with daily ibandronate found less bone-density improvement when breakfast followed after 30 instead of 60 minutes; it did not test each iron preparation with monthly tablets. Seek advice after a dosing error rather than taking a replacement or double ibandronate dose.
Evidence and practical considerations
Absorption & effectiveness
Take oral iron separately from an ibandronate tablet, with ibandronate first and at least 60 minutes before iron. The supported concern is interference with oral drug absorption. The inspected sources do not establish a separate, pair-specific increase in toxicity from this combination.
- Exact scope
- Oral iron preparations with oral ibandronate sodium. Intravenous iron and intravenous ibandronate are outside this intestinal co-administration assessment. with oral ibandronate sodium tablets
- Medication form and route
- oral ibandronate sodium tablets
- Timing or duration
- Timing applies on each prescribed oral dose day. Nutrient adequacy is an ongoing treatment consideration. Clinical trial durations and limitations are recorded in each source.
What remains uncertain
- The absorption and timing precaution is supported, while an additional side-effect claim remains insufficiently substantiated. A trial with daily ibandronate found less bone-density improvement when breakfast followed after 30 instead of 60 minutes; it did not test each iron preparation with monthly tablets. Seek advice after a dosing error rather than taking a replacement or double ibandronate dose.
Factors that may matter: Medication route and release formulation; Supplement mineral content and chemical preparation; Timing relative to breakfast and other oral products.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral ibandronate sodium tablets for postmenopausal osteoporosis.
Calcium, aluminum, magnesium and iron products are likely to interfere with absorption. Take the tablet first and wait at least 60 minutes before food, beverages other than plain water and other oral products. Supplement calcium and vitamin D if dietary intake is inadequate.
How this applies: Applies to oral iron-containing medicinal or supplement products under the stated medication formulation. Individual salt effects and quantitative outcome differences are not established. Exact scope: Oral iron preparations with oral ibandronate sodium. Intravenous iron and intravenous ibandronate are outside this intestinal co-administration assessment.
The label does not quantify every exact mineral or formula, prove pair-specific added toxicity, or establish the tablet absorption mechanism for intravenous use.
Source 2: peer-reviewed randomized clinical trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Postmenopausal women aged 55-80 with osteoporosis in a 48-week randomized open-label study; sample size not given in the inspected abstract.
Lumbar-spine BMD increased 3.07% with the 30-minute fast and 4.95% with the 60-minute fast. The shorter fast failed the prespecified non-inferiority criterion.
How this applies: Supports the oral ibandronate post-dose fasting interval; does not measure an isolated iron interaction or the monthly tablet effect. Exact scope: Oral iron preparations with oral ibandronate sodium. Intravenous iron and intravenous ibandronate are outside this intestinal co-administration assessment.
Breakfast timing study of a daily regimen, not a trial of an individual supplement with monthly tablets. Abstract-only access; no recommendation to increase the prescribed dose is adopted.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current oral formulation labels, route boundaries and original dosing evidence assessed. Exact existing statements adjudicated and article prepared. Clinical sign-off not recorded. | |
| Research summary published |
Article revision: 13cdf3844cd0e804
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.